7 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion StrokeCerebral Small Vessel Diseases, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderRecruitingNot applicable2026-09-11NCT06649240
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKEEmbolism and Thrombosis, antiphospholipid syndrome, autoimmune disease, brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, immune system disorder, ischemic stroke, nervous system disorder, stroke disorder, thrombotic disease, transient ischemic attack, vascular disorderActive, not recruitingPhase 42026-09-11NCT05995600
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic TherapyArterial Occlusive Diseases, Digestive System Diseases, Gastrointestinal Hemorrhage, Hemorrhage, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute coronary syndrome, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, digestive system disorder, duodenal disorder, heart disorder, intestinal disorder, ischemic disease, myocardial infarction, myocardial ischemia, peptic ulcer disease, stomach disorder, vascular disorderRecruitingPhase 42026-08-28NCT04416581
Tegoprazan for Prevention of Gastrointestinal Complication in Ischemic Stroke Patients on Antiplatelet Therapy (TegoStroke)Acute Ischemic Stroke, Digestive System Diseases, Gastrointestinal Hemorrhage, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, digestive system disorder, ischemic stroke, nervous system disorder, stroke disorder, transient ischemic attack, vascular disorderRecruitingPhase 32026-07-08NCT07687706
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathyActive, not recruitingPhase 32025-10-02NCT05531526
A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 22025-09-15NCT06821945
Efficacy and Safety Study of Isuzinaxib in Subjects With DKDDiabetes Complications, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, diabetes mellitus, diabetic kidney disease, endocrine system disorder, kidney disorder, urinary system disorderRecruitingPhase 22025-07-18NCT06962098